Statin therapy should not be discontinued in patients with Intracerebral hemorrhage

Stroke

Volumn 44, Issue 7, 2013, Pages 2060-2061

  Bustamante, Alejandro ^a   Montaner, Joan ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

intracerebral hemorrhage; neuroprotection; simvastatin; statins; stroke

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SIMVASTATIN;

BRAIN HEMORRHAGE; BRAIN ISCHEMIA; DISEASE ASSOCIATION; HUMAN; HYPOCHOLESTEROLEMIA; NEUROPROTECTION; NOTE; PRIORITY JOURNAL;

INTRACEREBRAL HEMORRHAGE; NEUROPROTECTION; SIMVASTATIN; STATINS; STROKE;

BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE;

EID: 84879955955     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.113.000916     Document Type: Note

References (4)

1. Tapia-Prez JH, Rupa R, Zilke R, Gehring S, Voellger B, Schneider T. Continued statin therapy could improve the outcome after spontaneous intracerebral hemorrhage. Neurosurg Rev. 2013;36:279-287; discussion 287
2. Yang D, Knight RA, Han Y, Karki K, Zhang J, Chopp M, et al. Statins protect the blood brain barrier acutely after experimental intracerebral hemorrhage. J Behav Brain Sci. 2013;3:100-106
3. Haussen DC, Henninger N, Kumar S, Selim M. Statin use and microbleeds in patients with spontaneous intracerebral hemorrhage. Stroke. 2012;43:2677-2681
4. Kou J, Song M, Pattanayak A, Lim JE, Yang J, Cao D, et al. Combined treatment of A? immunization with statin in a mouse model of Alzheimers disease. J Neuroimmunol. 2012;244:70-83.